Efficacy and therapeutic rationale of ManahVeda Diabohealth Tablets in Diabetes Care: An Overview

Diabetes mellitus is a complex metabolic disorder marked by chronic hyperglycemia and associated with progressive complications affecting multiple organ systems. The limitations of conventional anti-diabetic therapies, including adverse effects and incomplete metabolic control, have driven interest toward holistic and multi-targeted approaches such as Ayurveda. ManahVeda Diabohealth (DH) Tablets are an Ayurvedic proprietary polyherbal formulation developed to support glycemic regulation and metabolic balance through synergistic herbal actions. The formulation contains standardized extracts of Momordica charantia (Karela), Gymnema sylvestre (Gudmar), Syzygium cumini (Jamun), Trigonella foenum-graecum (Fenugreek), Cinnamomum zeylanicum (Cinnamon), Pterocarpus marsupium (Vijaysar), Swertia chirata (Chirayata), Emblica officinalis (Amla), Withania somnifera (Ashwagandha), and Asphaltum punjabianum (Shilajit). These herbs are traditionally recognized for their antihyperglycemic, insulin-sensitizing, antioxidant, anti-inflammatory, and pancreatic protective properties. The therapeutic rationale of Diabohealth Tablets lies in their multi-mechanistic action, including enhancement of insulin secretion, improvement of peripheral glucose uptake, modulation of carbohydrate metabolism, reduction of oxidative stress, and restoration of metabolic homeostasis. From an Ayurvedic perspective, the formulation aids in correcting Agni dysfunction, balancing Kapha and Vata doshas, and addressing the pathophysiology of Madhumeha at both systemic and cellular levels. In addition to glycemic control, the formulation may contribute to improved energy levels, stress modulation, and overall quality of life. Collectively, ManahVeda Diabohealth Tablets represent a rational Ayurvedic intervention for integrative diabetes management. However, well-designed clinical studies are necessary to validate their long-term efficacy, safety, and therapeutic outcomes. Keywords: Diabetes mellitus; Ayurvedic medicine; Polyherbal formulation; Glycemic control; Madhumeha; ManahVeda Diabohealth Tablets

Authors

Institutions

Publication Details

Journal
Journal of Drug Delivery and Therapeutics
Published
2026-04-15
DOI
https://doi.org/10.22270/jddt.v16i4.7634
Primary Topic
Natural Antidiabetic Agents Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Efficacy and therapeutic rationale of ManahVeda Diabohealth Tablets in Diabetes Care: An Overview

Naseem Akhtar Khan, Ghulamuddin Sofi, Talat Nahid, Dr. Md Najibur Rahman et al.
Journal of Drug Delivery and Therapeutics
Natural Antidiabetic Agents Studies
article

Efficacy and therapeutic rationale of ManahVeda Diabohealth Tablets in Diabetes Care: An Overview

Naseem Akhtar Khan, Ghulamuddin Sofi, Talat Nahid, Dr. Md Najibur Rahman, Barkati Md Tarique
article en

Abstract

Diabetes mellitus is a complex metabolic disorder marked by chronic hyperglycemia and associated with progressive complications affecting multiple organ systems. The limitations of conventional anti-diabetic therapies, including adverse effects and incomplete metabolic control, have driven interest toward holistic and multi-targeted approaches such as Ayurveda. ManahVeda Diabohealth (DH) Tablets are an Ayurvedic proprietary polyherbal formulation developed to support glycemic regulation and metabolic balance through synergistic herbal actions. The formulation contains standardized extracts of Momordica charantia (Karela), Gymnema sylvestre (Gudmar), Syzygium cumini (Jamun), Trigonella foenum-graecum (Fenugreek), Cinnamomum zeylanicum (Cinnamon), Pterocarpus marsupium (Vijaysar), Swertia chirata (Chirayata), Emblica officinalis (Amla), Withania somnifera (Ashwagandha), and Asphaltum punjabianum (Shilajit). These herbs are traditionally recognized for their antihyperglycemic, insulin-sensitizing, antioxidant, anti-inflammatory, and pancreatic protective properties. The therapeutic rationale of Diabohealth Tablets lies in their multi-mechanistic action, including enhancement of insulin secretion, improvement of peripheral glucose uptake, modulation of carbohydrate metabolism, reduction of oxidative stress, and restoration of metabolic homeostasis. From an Ayurvedic perspective, the formulation aids in correcting Agni dysfunction, balancing Kapha and Vata doshas, and addressing the pathophysiology of Madhumeha at both systemic and cellular levels. In addition to glycemic control, the formulation may contribute to improved energy levels, stress modulation, and overall quality of life. Collectively, ManahVeda Diabohealth Tablets represent a rational Ayurvedic intervention for integrative diabetes management. However, well-designed clinical studies are necessary to validate their long-term efficacy, safety, and therapeutic outcomes. Keywords: Diabetes mellitus; Ayurvedic medicine; Polyherbal formulation; Glycemic control; Madhumeha; ManahVeda Diabohealth Tablets

Journal of Drug Delivery and TherapeuticsVol. 16(4)
Patna Medical College and Hospital (IN), All India Institute of Medical Sciences Bhopal (IN), Government Ayurvedic College and Hospital (IN), Tibet Autonomous Region People's Hospital (CN), Regional Research Institute of Unani Medicine (IN)
Good health and well-being
Openalex Percentile: Top 23%
Natural Antidiabetic Agents Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.